Avoiding mistakes in calculating the number needed to treat in severe COPD.

Suppr

超能文献

作者信息

Aaron Shawn D

出版信息

Am J Respir Crit Care Med. 2007 Jun 15;175(12):1347; author reply 1347-8. doi: 10.1164/ajrccm.175.12.1347a.

DOI:10.1164/ajrccm.175.12.1347a

PMID:17545461

Abstract

摘要

相似文献

Avoiding mistakes in calculating the number needed to treat in severe COPD.

Am J Respir Crit Care Med. 2007 Jun 15;175(12):1347; author reply 1347-8. doi: 10.1164/ajrccm.175.12.1347a.

Do we need three players in COPD treatment?

Respiration. 2013;86(4):275-6. doi: 10.1159/000353553. Epub 2013 Aug 28.

Tiotropium in combination with placebo, salmeterol, or fluticasone salmeterol for chronic obstructive pulmonary disease: possible confounding effect of treatment withdrawal?

Ann Intern Med. 2007 Dec 18;147(12):882; author reply 882-3. doi: 10.7326/0003-4819-147-12-200712180-00011.

Is salmeterol/fluticasone propionate equivalent to tiotropium bromide in the treatment of COPD?

Am J Respir Crit Care Med. 2008 Jul 1;178(1):105; author reply 106-7. doi: 10.1164/ajrccm.178.1.105.

Hospitalizations with severe COPD.

Am J Respir Crit Care Med. 2007 Jun 1;175(11):1207; author reply 1207-8. doi: 10.1164/ajrccm.175.11.1207a.

Tiotropium in combination with placebo, salmeterol, or fluticasone-salmeterol for treatment of chronic obstructive pulmonary disease: a randomized trial.

Ann Intern Med. 2007 Apr 17;146(8):545-55. doi: 10.7326/0003-4819-146-8-200704170-00152. Epub 2007 Feb 19.

Predictors of pulmonary function response to treatment with salmeterol/fluticasone in patients with chronic obstructive pulmonary disease.

J Korean Med Sci. 2011 Mar;26(3):379-85. doi: 10.3346/jkms.2011.26.3.379. Epub 2011 Feb 25.

[New studies refute steroid opponents. COPD--after all a case for corticosteroids?].

MMW Fortschr Med. 2003 Jun 12;145(24):20.

Effect of pharmacotherapy on rate of decline of FEV(1) in the TORCH study.

Am J Respir Crit Care Med. 2009 Mar 1;179(5):426; author reply 426-7. doi: 10.1164/ajrccm.179.5.426.

Combined salmeterol and fluticasone for COPD.

Lancet. 2003 May 10;361(9369):1651; author reply 1652-3. doi: 10.1016/S0140-6736(03)13272-2.

引用本文的文献

Exaggeration of treatment benefits using the "event-based" number needed to treat.

CMAJ. 2008 Sep 23;179(7):669-71. doi: 10.1503/cmaj.080018.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Avoiding mistakes in calculating the number needed to treat in severe COPD.

Am J Respir Crit Care Med. 2007 Jun 15;175(12):1347; author reply 1347-8. doi: 10.1164/ajrccm.175.12.1347a.

Do we need three players in COPD treatment?

Respiration. 2013;86(4):275-6. doi: 10.1159/000353553. Epub 2013 Aug 28.

Tiotropium in combination with placebo, salmeterol, or fluticasone salmeterol for chronic obstructive pulmonary disease: possible confounding effect of treatment withdrawal?

Ann Intern Med. 2007 Dec 18;147(12):882; author reply 882-3. doi: 10.7326/0003-4819-147-12-200712180-00011.

Is salmeterol/fluticasone propionate equivalent to tiotropium bromide in the treatment of COPD?

Am J Respir Crit Care Med. 2008 Jul 1;178(1):105; author reply 106-7. doi: 10.1164/ajrccm.178.1.105.

Hospitalizations with severe COPD.

Am J Respir Crit Care Med. 2007 Jun 1;175(11):1207; author reply 1207-8. doi: 10.1164/ajrccm.175.11.1207a.

Tiotropium in combination with placebo, salmeterol, or fluticasone-salmeterol for treatment of chronic obstructive pulmonary disease: a randomized trial.

Ann Intern Med. 2007 Apr 17;146(8):545-55. doi: 10.7326/0003-4819-146-8-200704170-00152. Epub 2007 Feb 19.

Predictors of pulmonary function response to treatment with salmeterol/fluticasone in patients with chronic obstructive pulmonary disease.

J Korean Med Sci. 2011 Mar;26(3):379-85. doi: 10.3346/jkms.2011.26.3.379. Epub 2011 Feb 25.

[New studies refute steroid opponents. COPD--after all a case for corticosteroids?].

MMW Fortschr Med. 2003 Jun 12;145(24):20.

Effect of pharmacotherapy on rate of decline of FEV(1) in the TORCH study.

Am J Respir Crit Care Med. 2009 Mar 1;179(5):426; author reply 426-7. doi: 10.1164/ajrccm.179.5.426.

Combined salmeterol and fluticasone for COPD.

Lancet. 2003 May 10;361(9369):1651; author reply 1652-3. doi: 10.1016/S0140-6736(03)13272-2.

引用本文的文献

Exaggeration of treatment benefits using the "event-based" number needed to treat.

CMAJ. 2008 Sep 23;179(7):669-71. doi: 10.1503/cmaj.080018.